We are live on ! Find out more
CIM

Contravisory Investment Management Portfolio holdings

AUM $566M
1-Year Est. Return 42.93%
This Fund
S&P 500
This Quarter Est. Return
+2.58%
1 Year Est. Return
+42.93%
3 Year Est. Return
+129.34%
5 Year Est. Return
+198.47%
10 Year Est. Return
+603.03%
AUM
$468M
AUM Growth
+$118K
Cap. Flow
-$5.51M
Cap. Flow %
-1.18%
Top 10 Hldgs %
23.9%
Holding
440
New
97
Increased
70
Reduced
108
Closed
48

Top Buys

Rank Stock Value
1
OKE icon
Oneok
OKE
+$9.66M
2
SN icon
SharkNinja
SN
+$8.56M
3
CMS icon
CMS Energy
CMS
+$8.41M
4
AVB icon
AvalonBay Communities
AVB
+$8.19M
5
CAT icon
Caterpillar
CAT
+$8.05M

Top Sells

Rank Stock Value
1
MCK icon
McKesson
MCK
+$12.5M
2
AMAT icon
Applied Materials
AMAT
+$9.22M
3
WLK icon
Westlake Corp
WLK
+$9.14M
4
CTLT
CATALENT, INC.
CTLT
+$7.93M
5
LRCX icon
Lam Research
LRCX
+$7.87M

Sector Composition

Rank Sector Weight
1 Financials 20.84%
2 Technology 16.2%
3 Industrials 12.29%
4 Consumer Discretionary 10.68%
5 Communication Services 10.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OSIS icon
201
OSI Systems
OSIS
$3.89B
$258K 0.06%
1,542
MHO icon
202
M/I Homes
MHO
$3.84B
$252K 0.05%
1,897
PTGX icon
203
Protagonist Therapeutics
PTGX
$9.44B
$251K 0.05%
+6,498
New +$283K
UE icon
204
Urban Edge Properties
UE
$2.73B
$245K 0.05%
11,417
NVT icon
205
nVent Electric
NVT
$26.7B
$243K 0.05%
3,572
-35
-1% -$2.58K
PG icon
206
Procter & Gamble
PG
$339B
$241K 0.05%
1,439
+6
+0.4% +$1.02K
PRK icon
207
Park National Corp
PRK
$3.67B
$232K 0.05%
1,351
SAN icon
208
Banco Santander
SAN
$210B
$229K 0.05%
50,197
-260
-0.5% -$1.25K
HSBC icon
209
HSBC
HSBC
$356B
$229K 0.05%
4,624
-24
-0.5% -$1.11K
RY icon
210
Royal Bank of Canada
RY
$293B
$227K 0.05%
1,883
+40
+2% +$4.94K
HNI icon
211
HNI Corp
HNI
$3.59B
$227K 0.05%
4,501
+220
+5% +$11.8K
RACE icon
212
Ferrari
RACE
$72.5B
$223K 0.05%
525
-2
-0.4% -$902
AGIO icon
213
Agios Pharmaceuticals
AGIO
$1.93B
$222K 0.05%
+6,752
New +$317K
TEVA icon
214
Teva Pharmaceuticals
TEVA
$41.2B
$221K 0.05%
+10,009
New +$182K
MELI icon
215
Mercado Libre
MELI
$92.3B
$219K 0.05%
129
-9
-7% -$17.5K
RDY icon
216
Dr. Reddy's Laboratories
RDY
$10.2B
$219K 0.05%
13,886
+111
+0.8% +$1.67K
RELX icon
217
RELX
RELX
$62B
$218K 0.05%
4,802
-3
-0.1% -$140
WLY icon
218
John Wiley & Sons Class A
WLY
$2.66B
$214K 0.05%
4,890
HCC icon
219
Warrior Met Coal
HCC
$4.86B
$213K 0.05%
3,919
ING icon
220
ING
ING
$102B
$210K 0.04%
13,381
+77
+0.6% +$1.25K
ICFI icon
221
ICF International
ICFI
$1.72B
$207K 0.04%
1,735
AEG icon
222
Aegon
AEG
$14.1B
$199K 0.04%
33,830
+27
+0.1% +$169
DB icon
223
Deutsche Bank
DB
$71.5B
$197K 0.04%
11,559
+152
+1% +$2.61K
UL icon
224
Unilever
UL
$136B
$197K 0.04%
+3,083
New +$208K
FUN icon
225
Cedar Fair
FUN
$1.67B
$195K 0.04%
4,043
-445
-10% -$19.5K

Similar funds

Contravisory Investment Management's Q4 2024 Portfolio in Review

As of Q4 2024, Contravisory Investment Management held 440 positions worth $468M, up 0.03% from $468M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Contravisory Investment Management's Q4 2024 filing shows 97 new, 70 increased, 108 reduced and 48 closed positions. Its largest new stake was Oneok: 94,453 shares worth $9.48M. The largest sale was McKesson, an estimated $12.5M.

By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 20% a quarter earlier, followed by Technology and Industrials.

  • Contravisory Investment Management's largest Q4 2024 buy was Oneok: 94,453 shares worth $9.48M.
  • Contravisory Investment Management added most to Caterpillar in Q4 2024, an estimated $8.05M increase.
  • Contravisory Investment Management's biggest Q4 2024 reduction was KLA, cutting an estimated $1.33M.
  • Contravisory Investment Management fully exited McKesson in Q4 2024, selling an estimated $12.5M.
  • Contravisory Investment Management's ten largest holdings make up 24% of its $468M portfolio in Q4 2024.
  • Contravisory Investment Management opened 97 new positions and closed 48 in Q4 2024.
  • Contravisory Investment Management's portfolio value rose 0.03% quarter-over-quarter to $468M.

Based on Contravisory Investment Management's 13F filing for Q4 2024, filed 14 Jan 2025.